Epitalon Dosing Protocol
Epitalon (Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched for telomerase activation. Based on epithalamin from the pineal gland, it targets cellular aging through telomere maintenance during brief periodic interventions.
Key Points
Step-by-Step Guide
Standard Dosing
The most discussed protocol is 5-10 mg/day subcutaneously. Some split the daily dose into morning and evening injections.
Cycle Design
Short cycles: 10-20 days of daily injections, then 4-6 months off. Derived from Russian clinical research with epithalamin.
Injection Technique
Subcutaneous in abdominal fat pad. Due to short cycle length, site rotation is straightforward. Reconstitute with bacteriostatic water.
Consider Monitoring
Telomere length testing (SpectraCell, RepeatDx) provides baseline and follow-up. Changes are gradual and may require 6-12 months to measure.
Repeat Cycles
2-3 cycles per year, spaced 4-6 months apart. The rationale: periodically activate telomerase without chronic stimulation.
Warnings & Precautions
- !No FDA approval or Western clinical trials exist.
- !Chronic telomerase activation has theoretical cancer risk.
- !Long-term safety is completely unknown.
- !Telomere testing is expensive with variable results between labs.
Frequently Asked Questions
Why are Epitalon cycles so short?
Brief telomerase activation may suffice to maintain telomeres without the risks of chronic stimulation. Cancer cells use telomerase for immortality, so caution with prolonged use is warranted.
Can Epitalon extend telomeres?
Cell culture studies show telomerase activation and telomere extension. Russian clinical studies reported increased telomere length in elderly patients. Results have not been replicated in large Western trials.
Should I test telomeres before starting?
Baseline testing provides a reference but has limitations: high test-retest variability, inconsistent results between labs, and debated clinical significance of small changes.